RxDoctor Payments Data

Thomas Bishop, MD

Vascular & Interventional Radiology · Blacksburg, VANPI 1750418315

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,860 of the $5,323 with a category attached, or 72.5%. Penumbra, Inc. accounts for 88.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,439 and has fallen 90.4% since, to $235 in 2024.

$5,323in general payments, 2019–2025

Across 18 payments — averaging $295.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$5K
  • Neptune Medical Inc.$182
  • Inari Medical, Inc.$170
  • Terumo Medical Corporation$113
  • Sirtex Medical Inc$81
  • Boston Scientific$52
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$3,86073%
  • Food & beverage$1,36326%
  • Education$1002%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,323 in reported general payments places this provider in the 70th percentile of 136 vascular & interventional radiology providers in Virginia.

See all vascular & interventional radiology providers in Virginia

Medicare billing

Part B allowed, 2024
$65,295
Medicare patients
258
Services billed
767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$6,886

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Blacksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →